SCHEMBL7094297

SCHEMBL7094297

O=C1CCN(Cc2cc(Cc3c[nH]c4ccccc34)cc3ccccc23)C(=O)CN1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ RAB9A P51151 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ LMNA P02545 3/20 0.40
▸ HTT P42858 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ TACR1 P25103 2/20 0.39
▸ AHR P35869 2/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ GPR84 Q9NQS5 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ HTR6 P50406 2/20 0.38
▸ TACR2 P21452 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7011147 0.82 CHRNA7 (0.39) SMN1; SMN2DRD2DRD4DRD3
SCHEMBL5234914 0.80 CYP2C9 (0.41) SMN1; SMN2MEN1KMT2AMAPTDRD4
SCHEMBL3120511 0.74 BCHE (0.52) BCHECYP2D6RAB9ASMN1; SMN2MEN1
SCHEMBL2754242 0.69 RAB9A (0.70) BCHECYP2D6RAB9ASMN1; SMN2KMT2A
SCHEMBL5234092 0.66 KMT2A (0.67) SMN1; SMN2MEN1KMT2ATACR1CYP3A4
SCHEMBL3996399 0.64 BCHE (0.55) BCHECYP2D6RAB9ASMN1; SMN2KMT2A
SCHEMBL553605 0.62 MEN1 (1.00) BCHECYP2D6SMN1; SMN2MEN1KMT2A
SCHEMBL30648199 0.62 MEN1 (1.00) BCHECYP2D6SMN1; SMN2MEN1KMT2A
Arundine SCHEMBL325162 0.61 MEN1 (1.00) BCHECYP2D6MEN1KMT2AHTT
SCHEMBL28961243 0.61 MEN1 (0.61) CYP2D6SMN1; SMN2MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296961-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-02 — — EP disclosed
WO-2001090083-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 — — WO disclosed
Send feedback